Abingdon Health Plc (ABDX.L) LSE
8.25
+0(+0.00%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
8.25
+0(+0.00%)
Currency In GBp
Address
York Biotech Campus
York, YO41 1LZ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 19 0440 6050
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
113
First IPO Date
December 15, 2020
| Name | Title | Pay | Year Born |
| Christopher William Hand | Executive Chairman | 77,000 | 1961 |
| Chris Henry Francis Yates | President of & Director Abingdon Health USA Inc. | 287,000 | 1974 |
| Laura Towse | Controller | 0 | N/A |
| Mark Jones | Chief Operating Officer | 0 | N/A |
| Thomas Edward Hayes | Secretary, Chief Financial Officer & Director | 0 | 1976 |
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.